BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9925030)

  • 1. Carvedilol inhibition of lipid peroxidation. A new antioxidative mechanism.
    Tadolini B; Franconi F
    Free Radic Res; 1998 Nov; 29(5):377-87. PubMed ID: 9925030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Fe3+ on Fe2+-dependent lipid peroxidation in phospholipid liposomes.
    Ohyashiki T; Kadoya A; Kushida K
    Chem Pharm Bull (Tokyo); 2002 Feb; 50(2):203-7. PubMed ID: 11848210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron (III) stimulation of lipid hydroperoxide-dependent lipid peroxidation.
    Tadolini B; Cabrini L; Menna C; Pinna GG; Hakim G
    Free Radic Res; 1997 Dec; 27(6):563-76. PubMed ID: 9455692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant action of the antihypertensive drug, carvedilol, against lipid peroxidation.
    Noguchi N; Nishino K; Niki E
    Biochem Pharmacol; 2000 May; 59(9):1069-76. PubMed ID: 10704936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of iron (III) stimulation of lipid peroxidation.
    Tadolini B; Hakim G
    Free Radic Res; 1996 Sep; 25(3):221-7. PubMed ID: 8889488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The involvement of iron in lipid peroxidation. Importance of ferric to ferrous ratios in initiation.
    Braughler JM; Duncan LA; Chase RL
    J Biol Chem; 1986 Aug; 261(22):10282-9. PubMed ID: 3015924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTHQ (1-O-hexyl-2,3,5-trimethylhydroquinone), an anti-lipid-peroxidative compound: its chemical and biochemical characterizations.
    Hino T; Kawanishi S; Yasui H; Oka S; Sakurai H
    Biochim Biophys Acta; 1998 Sep; 1425(1):47-60. PubMed ID: 9813237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells.
    Yue TL; Mckenna PJ; Gu JL; Cheng HY; Ruffolo RR; Feuerstein GZ
    Hypertension; 1993 Dec; 22(6):922-8. PubMed ID: 7902335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
    Yue TL; Cheng HY; Lysko PG; McKenna PJ; Feuerstein R; Gu JL; Lysko KA; Davis LL; Feuerstein G
    J Pharmacol Exp Ther; 1992 Oct; 263(1):92-8. PubMed ID: 1357162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils.
    Yue TL; McKenna PJ; Ruffolo RR; Feuerstein G
    Eur J Pharmacol; 1992 Apr; 214(2-3):277-80. PubMed ID: 1355437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potent antioxidant, SB209995, inhibits oxygen-radical-mediated lipid peroxidation and cytotoxicity.
    Feuerstein R; Yue TL
    Pharmacology; 1994 Jun; 48(6):385-91. PubMed ID: 8047557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The requirement for iron (III) in the initiation of lipid peroxidation by iron (II) and hydrogen peroxide.
    Minotti G; Aust SD
    J Biol Chem; 1987 Jan; 262(3):1098-104. PubMed ID: 3027077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant properties of carvedilol: inhibition of lipid peroxidation, protein oxidation and superoxide generation.
    Suzuki Y; Tanaka M; Sohmiya M; Yoshida T; Okamoto K
    Neurol Res; 2003 Oct; 25(7):749-53. PubMed ID: 14579794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical-scavenging and iron-chelating properties of carvedilol, an antihypertensive drug with antioxidative activity.
    Oettl K; Greilberger J; Zangger K; Haslinger E; Reibnegger G; Jürgens G
    Biochem Pharmacol; 2001 Jul; 62(2):241-8. PubMed ID: 11389884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-carnosine (beta-alanyl-L-histidine) and carcinine (beta-alanylhistamine) act as natural antioxidants with hydroxyl-radical-scavenging and lipid-peroxidase activities.
    Babizhayev MA; Seguin MC; Gueyne J; Evstigneeva RP; Ageyeva EA; Zheltukhina GA
    Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):509-16. PubMed ID: 7998987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of taurine and hypotaurine on lipid peroxidation.
    Tadolini B; Pintus G; Pinna GG; Bennardini F; Franconi F
    Biochem Biophys Res Commun; 1995 Aug; 213(3):820-6. PubMed ID: 7654243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The requirement for ferric in the initiation of lipid peroxidation by chelated ferrous iron.
    Bucher JR; Tien M; Aust SD
    Biochem Biophys Res Commun; 1983 Mar; 111(3):777-84. PubMed ID: 6838585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of membrane lipid peroxidation by a radical scavenging mechanism: a novel function for hydroxyl-containing ionophores.
    Grijalba MT; Andrade PB; Meinicke AR; Castilho RF; Vercesi AE; Schreier S
    Free Radic Res; 1998 Mar; 28(3):301-18. PubMed ID: 9688216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of heart mitochondrial lipid peroxidation by non-toxic concentrations of carvedilol and its analog BM-910228.
    Santos DJ; Moreno AJ
    Biochem Pharmacol; 2001 Jan; 61(2):155-64. PubMed ID: 11163330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential inhibition of superoxide, hydroxyl and peroxyl radicals by nimesulide and its main metabolite 4-hydroxynimesulide.
    Maffei Facino R; Carini M; Aldini G; Saibene L; Morelli R
    Arzneimittelforschung; 1995 Oct; 45(10):1102-9. PubMed ID: 8595069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.